CN1876094A - A drug-breaking medicine and preparation method thereof - Google Patents
A drug-breaking medicine and preparation method thereof Download PDFInfo
- Publication number
- CN1876094A CN1876094A CNA2006100602497A CN200610060249A CN1876094A CN 1876094 A CN1876094 A CN 1876094A CN A2006100602497 A CNA2006100602497 A CN A2006100602497A CN 200610060249 A CN200610060249 A CN 200610060249A CN 1876094 A CN1876094 A CN 1876094A
- Authority
- CN
- China
- Prior art keywords
- drug
- medicine
- breaking medicine
- breaking
- wine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a medicament for drug abstinence, which comprises the following raw materials (by weight portion): long-noded pit viper 14.25-15.75%, snake slough 9.5-10.5%, buthus martensi kirsch 14.25-15.75%, batryticated silkworm 9.5-10.5%, Crocus sativus L. 6.65-7.35%, secretio bufonis 1.9-2.1%, rhubarb horsetails 7.6-8.4%, barbat skullcap 7.6-8.4%, root of Chinese trichosannthes 4.75-5.25%, coptis root 9.5-10.5%, bark of peony root 4.75-5.25%, and anemarrhena rhizome 4.75-5.25%.
Description
Technical field
The present invention relates to a kind of medicine that is used to quit drug abuse, in particular, a kind of drug-breaking medicine and preparation method thereof.
Background technology
Drugs come from Semen Papaveris, the Fructus Cannabis Folium Cocoe belongs to the plant alkaloid produced in the root, stem, leaf, seed, shell of undershrub plant, exists to step health acid salt form, comprehensive composition claims Opium, contain 30 various plants alkali compositions, some composition is wherein decomposed again, cough up that he is bright, tetrahydrocannabinol etc. because of, morphine, cocaine, Di Mayin, papaverine, cryptocavine, hydrogenation but extract purer sea.And then produce drugs such as amphetamine central stimulant, head-shaking pill, the people is excessive to suck direct injury human body, make the cerebral nerve disequilibrium, the central nervous system very easily produces the dependency to drugs, cause the sense of taste, the neural monophagia that produces of hobby, other disease is availed oneself of the opportunity to get in, and all morbid state occurs, the grievous injury health jeopardizes people's life.Therefore drugs are called " worldwide pestilence " by people, along with going deep into of Chinese society expanding economy and reform and opening-up, drugs have been penetrated in the middle of the social life, the safety of the people's healthy and lives and properties in positive serious harm, in case catch drug addiction, just be difficult to give up, the numerous drug abstainer spirit and the human body are all very painful.
Present existing several drug rehabilitation methods: (1), substitution method: the treating the poisonous disease with poisonous drugs method, treat with the drugs substitute that contains toxin; (2), diminishing method: constantly reduce the content of drugs,, adopt their treatments of successively decreasing such as commonly used methadone, clonidine, fourth third promise coffee and the lofexidine; (3), induced hibernation method: use Morpheus, make the people enter resting state.
But the medicine that existing Therapeutic Method is adopted not only costs an arm and a leg, and withdrawal symptom is obvious during medication, and has toxic and side effects, usually make junkie after giving up drug addiction, bring other negative effect to health, and prior treatment method, relapse rate reaches more than 95 percent.
And, for the addict of drugs such as the heroin of catching the Opium class, morphine, dolantin, Fructus Cannabis, adopt existing drug rehabilitation method can produce a kind of feel embarrassed to mention frightened and painful, be difficult to really give up drug addiction.
Therefore, there is defective in prior art, needs to improve.
Summary of the invention
The object of the present invention is to provide a kind of drug-breaking medicine and preparation method thereof, be used to remove the drug addiction such as heroin, morphine, dolantin, Fructus Cannabis of Opium class, reduce drug rehabilitation cost and toxic and side effects, reduce withdrawal symptom and relapse rate.
Technical scheme of the present invention is as follows:
A kind of drug-breaking medicine, wherein, it is made up of following parts by weight of Chinese traditional medicine material: Agkistrodon 14.25%～15.75%; Periostracum Serpentis 9.5%～10.5%; Scorpio 14.25%～15.75%; Bombyx Batryticatus 9.5%～10.5%; Stigma Croci 6.65%～7.35%; Venenum Bufonis 1.9%～2.1%; Radix Et Rhizoma Rhei 7.6%～8.4%; Herba Scutellariae Barbatae 7.6%～8.4%; Radix Trichosanthis 4.75%～5.25%; Rhizoma Coptidis 9.5%～10.5%; Cortex Moutan 4.75%～5.25%; The Rhizoma Anemarrhenae 4.75%～5.25%.
Described drug-breaking medicine, wherein, wherein the consumption of each composition is an Agkistrodon 15%; Periostracum Serpentis 10%; Scorpio 15%; Bombyx Batryticatus 10%; Stigma Croci 7%; Venenum Bufonis 2%; Radix Et Rhizoma Rhei 8%; Herba Scutellariae Barbatae 8%; Radix Trichosanthis 5%; Rhizoma Coptidis 10%; Cortex Moutan 5%; The Rhizoma Anemarrhenae 5%.
Described drug-breaking medicine, wherein, described drug-breaking medicine external.
The preparation method of described drug-breaking medicine, it may further comprise the steps: pulverize, dry, sieve, weighing, mixed, high-temperature sterilization, glue.
Described preparation method, wherein, mixed back adds Mel concocts, and the weight ratio of described Mel and drug-breaking medicine is 0.125: 1.
Described preparation method, wherein, it is that 30% wine is concocted that mixed back adds alcohol content, the weight ratio of described wine and drug-breaking medicine is 0.175: 1.
Described preparation method, wherein, mixed back adds Mel and wine is concocted, and the weight ratio of described Mel and drug-breaking medicine is 0.125: 1; The weight ratio of described wine and drug-breaking medicine is 0.175: 1; The alcohol content of described wine is 30%.
Adopt such scheme, the present invention selects for use Chinese crude drug to be mixed with compound medicine for dropping drug, with seven days be a course of treatment, the drug addiction such as heroin, morphine, dolantin, Fructus Cannabis of Opium class are removed on no dependence ground in one to two course of treatment; Not only make junkie in short-term, rehabilitate addicts, also reduced drug rehabilitation cost and toxic and side effects, reduced withdrawal symptom and relapse rate.Simultaneously, the present invention also provides the preparation method and the purposes of drug-breaking medicine.
The specific embodiment
Below preferred embodiment of the present invention is described in detail.
The invention provides a kind of drug-breaking medicine, its preferred component composition is: Agkistrodon 15%; Periostracum Serpentis 10%; Scorpio 15%; Bombyx Batryticatus 10%; Stigma Croci 7%; Venenum Bufonis 2%; Radix Et Rhizoma Rhei 8%; Herba Scutellariae Barbatae 8%; Radix Trichosanthis 5%; Rhizoma Coptidis 10%; Cortex Moutan 5%; The Rhizoma Anemarrhenae 5%.In the essence Chinese crude drug, owing to its effective ingredient may change along with the Chinese crude drug place of production, quality or individual variation, therefore, may there be certain mobility scale in the concrete parts by weight of Chinese traditional medicine material that adopts of drug-breaking medicine of the present invention, practical experience according in invention process and the use is set at 5% with mobility scale.
Therefore, a kind of drug-breaking medicine of the present invention, it is made up of following parts by weight of Chinese traditional medicine material: Agkistrodon 14.25%～15.75%; Periostracum Serpentis 9.5%～10.5%; Scorpio 14.25%～15.75%; Bombyx Batryticatus 9.5%～10.5%; Stigma Croci 6.65%～7.35%; Venenum Bufonis 1.9%～2.1%; Radix Et Rhizoma Rhei 7.6%～8.4%; Herba Scutellariae Barbatae 7.6%～8.4%; Radix Trichosanthis 4.75%～5.25%; Rhizoma Coptidis 9.5%～10.5%; Cortex Moutan 4.75%～5.25%; The Rhizoma Anemarrhenae 4.75%～5.25%.
Wherein, Rhizoma Coptidis of the present invention is the cohosh Rhizoma Coptidis.
The function that various one-tenth branch in the prescription have is as follows.Agkistrodon: dispel the wind, collateral dredging, relieving convulsion; Periostracum Serpentis: expelling wind for relieving convulsion, detoxifcation; Scorpio: heat-clearing and toxic substances removing; Bombyx Batryticatus: expelling wind for relieving convulsion; Dissipating phlegm and resolving masses; Stigma Croci: blood circulation promoting and blood stasis dispelling, removing pathogenic heat from blood and toxic substance from the body, resolving stagnation for tranquilization; Venenum Bufonis: detoxifcation pain relieving, the refreshment of having one's ideas straightened out; Radix Et Rhizoma Rhei: purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body; Herba Scutellariae Barbatae: heat-clearing and toxic substances removing, blood stasis dispelling diuresis; Radix Trichosanthis: clearing away heat and promoting production of body fluid, lung-heat type cough; Rhizoma Coptidis: heat clearing and damp drying, eliminating fire and detoxication; Cortex Moutan: clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, maculae caused by violent heat pathogen; The Rhizoma Anemarrhenae: clearing away heat-fire, promote the production of body fluid and moisturize.
Drug-breaking medicine of the present invention, wherein, described drug-breaking medicine external.Best external position is people's umbilicus position, can reach significant drug abstinence.Except umbilicus, can also be applied to other position of human body, back etc. for example, but drug abstinence is all remarkable not as the umbilicus position.Simultaneously, the described drug-breaking medicine effect that also can reach drug rehabilitation for oral administration.
According to Chinese medicine meridian point and human anatomy theory, people's SHENQUE acupoint, that is people's umbilicus position are that human body first is breathed channel, connect the twelve regular channels, the vital organs of the human body, extremity hundred bones, face nine orifices, skin and flesh fascia.The active ingredient of medicine enters human body by the skin at umbilicus position, can remove the poisonous substance of human body, and discharges toxin from defecation.Drug-breaking medicine medication of the present invention is simple and convenient, and only needing can treating both the exterior and interior in the umbilicus position with drug application, takes effect fast, removes drug addiction.
Simultaneously, the present invention also provides the preparation method of described drug-breaking medicine, and it may further comprise the steps: pulverize, dry, sieve, weighing, mixed, high-temperature sterilization, glue.To dry behind each the tcm components material pulverize separately after preferred; The dry powder that obtains sieves to guarantee that it does not contain bulky grain; Carry out weighing then, by weight mixed each tcm components material; Carrying out glue after high-temperature sterilization handles.
Wherein, sieving is by 100 mesh sieve holes; Can not can continue to use or abandon through pulverizing, dry the back again by the bulky grain of sieve aperture when sieving.Each step adopts conventional method.
Preparation method of the present invention adds Mel in mixed back and concocts, and the weight ratio of described Mel and drug-breaking medicine is 0.125: 1.Adding Mel can increase the softness of patent medicine.In actual use, according to the practical experience in invention process and the use, the weight ratio that adds Mel and drug-breaking medicine can be 0.075: 1～0.175: 1, with the demand of realistic medication.
Preparation method of the present invention adds alcohol content and is 30% wine and concocts in mixed back, the weight ratio of described wine and drug-breaking medicine is 0.175: 1.Adding wine can increase the softness of patent medicine.Wine of the present invention can adopt rice wine, Chinese liquor etc.In actual use, according to the practical experience in invention process and the use, the weight ratio that adds wine and drug-breaking medicine can be 0.125～0.225: 1; The alcohol content of described wine can be 20%～40%, with the demand of realistic medication.Wherein, alcohol content is the wine that 30% wine is equivalent to about 30 degree.
Preparation method of the present invention can add Mel simultaneously after mixing and wine is concocted, and the weight ratio of described Mel and drug-breaking medicine is 0.125: 1; The weight ratio of described wine and drug-breaking medicine is 0.175: 1; The alcohol content of described wine is 30%.In actual use, the weight ratio of adding Mel and drug-breaking medicine is 0.075: 1～0.175: 1; The weight ratio that adds wine and drug-breaking medicine is 0.125: 1～0.225: 1; The alcohol content that adds wine is 20%～40%, with the demand of realistic medication.
Below provide a preferred embodiment that drug-breaking medicine of the present invention is described.Adopt through the high-quality Chinese crude drug of screening as follows:
Agkistrodon: 150 parts of Periostracum Serpentiss: 100 portions of Scorpios: 150 parts
Bombyx Batryticatus: 100 parts of Stigma Crocis: 70 parts of Venenum Bufoniss: 20 parts
Radix Et Rhizoma Rhei: 80 portions of Herba Scutellariae Barbataes: 80 parts of Radix Trichosanthis: 50 parts
Rhizoma Coptidis: 100 parts of Cortex Moutans: 50 parts of Rhizoma Anemarrhenaes: 50 parts
With above-mentioned ready Chinese crude drug, through pulverizes, dry, sieve, weighing, mix, high-temperature sterilization, glue get final product.Above-mentioned material can make 1000 parts of anti-additive medicaments.
Can also add the adjuvant composition after mixed and concoct for 300 parts, described adjuvant composition comprises 175 parts in rice wine, and Mel is concocted for 125 parts.
A drug-breaking medicine of the present invention is preferably 4 grams.In actual the use, according to the practical experience in invention process and the use, component can change to some extent, and a drug-breaking medicine all can reach comparatively satisfactory therapeutic effects at 3 grams～5 grams.
Drug-breaking medicine Pharmacodynamic test of active extract of the present invention is as follows.
Drug material: drug-breaking medicine of the present invention, every pill 4 grams; The medicinal liquid of experiment usefulness, every gram is for external application after 12 hours with 2ml eliminating cold for resuscitation water logging bubble.Heroin is provided by Jiangxi public security bureau, and naloxone hydrochloride is produced by Fourth Ring, Beijing pharmaceutical factory, lot number 960416.
Animal: Kunming mouse body weight 20g～24g, wistar rat body weight 190g～230g is provided by packet header medical college Experimental Animal Center.
One, to the influence of heroin induced mice physical dependence.
Get 50 of mices, male and female half and half are removed belly wool with electric hair cutter, are divided into 5 groups at random: (1) negative control group (2) heroin matched group (3) (4) (5) group is various dose drug-breaking medicine of the present invention.Except that (1) negative control group, each organizes the equal subcutaneous injection of mice (SC) heroin, according to dosage incremental method is from 6.25mg/kg, 2 times/day (12 hours at interval) increase progressively 3.75mg/kg every day, successive administration 7 days, cause the physical dependence of mice to heroin, when giving heroin, (1) (2) group abdominal part is coated with cold boiled water 2 times/day, 0.5ml/ time; (3) (4) group is coated with drug-breaking medicine medicinal liquid of the present invention and is respectively 0.5ml/ time 2 times/day and 4 times/day; (5) organize in urging addiction to be coated with drug-breaking medicine of the present invention twice 0.5ml/ time in preceding 2 hours, last is given behind the heroin 3 hours, and the equal lumbar injection of each mice (ip) naloxone 8mg/kg, record urge after the addiction in 15 minutes the mouse jump number of times and weight loss situation after 1 hour.
The results are shown in Table one, continuous 7 days SC heroin, mice produces physical dependence to heroin, and urge addiction with naloxone, withdrawal symptoms such as jump and weight loss can appear, drug-breaking medicine of the present invention (3) (4) group compares with the heroin matched group, and number of skips of mice and weight loss all obviously reduce (P＜0.01).Urge preceding 2 coatings of addiction that the mouse jump number of times is reduced, but body weight change and heroin matched group no significant difference.
Table one: heroin induced mice physical dependence influences test card (X ± S).
| Group | Number of animals (only) | Jump incidence rate (%) | Number of skips | Weight loss |
| (1) | 10 | - | 0 | 0.21±0.14 |
| (2) | 10 | 100 | 23.45±9.16 | 0.82±0.34 |
| (3) | 10 | 60 | 11.86±6.34 | 0.48±0.23 |
| (4) | 10 | 70 | 7.23±3.52 | 0.44±0.25 |
| (5) | 10 | 90 | 16.76±5.96 | 0.71±0.29 |
Two, the influence of rat physical dependence due to the heroin
Get 32 of rats, male and female half and half, remove belly wool with electric hair cutter, be divided into 4 groups at random: (1) negative control group, (2) heroin matched group, (3) (4) group is various dose drug-breaking medicine of the present invention, and (3) (4) group is coated with drug-breaking medicine medicinal liquid of the present invention and is respectively 1.21ml/ time 2 times/day and 4 times/day.Except that negative control group, each organizes the equal SC heroin of rat, according to dosage incremental method 2 times/day, increases progressively 3.75/kg every day from 6.25mg/kg, successive administration 7 days, cause rat that heroin is relied on, last is given behind the heroin 3 hours, and each organizes the equal ip naloxone of rat 8mg/kg addiction, record is urged after the addiction in 15 minutes the withdrawal symptom of rat and weight loss situation after 1 hour, and marks by willow Tian Zhisi point system.
The results are shown in Table two, continuous 7 days SC heroin, rat has produced physical dependence to heroin, urge addiction with naloxone this moment, as seen jump, turn round body, grit one's teeth, sialorrhea, withdrawal symptom such as suffer from diarrhoea and lose weight, but drug-breaking medicine external antagonism rat of the present invention is to the physical dependence of heroin, make to urge weight loss after the addiction, and the withdrawal symptom comprehensive grading obviously reduces.
Table two: the rat physical dependence influences test card (X ± S) due to the heroin.
| Group | Number of animals (only) | The withdrawal symptom scoring | Weight loss (gram) |
| (1) | 8 | 1.96±1.23 | 2.11±1.38 |
| (2) | 8 | 9.86±3.45 | 7.78±3.92 |
| (3) | 8 | 5.15±2.38 | 4.05±2.13 |
| (4) | 8 | 4.23±2.52 | 3.82±2.08 |
Three, natural withdrawal experiment.
Get 30 of mices, male and female half and half are divided 3 groups at random after the abdominal part unhairing, 1,2 groups of negative control group and drug-breaking medicine of the present invention.Negative control group is coated with cold boiled water 0.5ml/ time, 2 times/day; 1,2 groups of drug-breaking medicine of the present invention are coated with medicinal liquid 2 times/day and 4 times/day respectively, and 0.5ml/ time, coating or water are 10 days continuously, observe outward appearance, behavior and the body weight change of 48 hours animals after preceding 24 hours of drug withdrawal and the drug withdrawal.
Experimental result: before each treated animal drug withdrawal and behavior after the drug withdrawal, activity and outward appearance no abnormality seen, administration group and matched group body weight change no significant difference show that drug-breaking medicine of the present invention does not produce physical dependence.
Conclusion:
Above-mentioned experimental result shows: drug-breaking medicine external of the present invention can obviously alleviate the mice physical dependence due to the heroin; Also can obviously alleviate the rat physical dependence due to the heroin; But give mice medication 10 days continuously, do not produce physical dependence.
Below be dermal toxicity and the hypersensitive test that described drug-breaking medicine is carried out.Described drug-breaking medicine is a Lycoperdon polymorphum Vitt medicated powder, a 3g.Before the experiment medicated powder is added 4 times of water mixings and soak into the back use.
Four, guinea pig skin acute toxicity test.
4.1 Cavia porcellus intact skin acute toxicity test.
30 of albino guinea-pigs, body weight 280g～320g is divided into 3 groups at random, and 10 every group, male and female half and half.At back unhairing 6cm * 7cm, medicine is coated with medicinal liquid 4ml for 1 group after 24 hours earlier, and medicine is coated with medicinal liquid 2ml for 2 groups, and matched group is coated with distilled water 3ml, fixes with gauze, binder, glass paper, adhesive plaster wrapping, and every single cage of animal is raised.After 24 hours with the residual thing that tried of warm water flush away.Observe immediately, observe later every day, continuous 7 days.
The result: the coating guinea pig skin does not have red and swollen phenomenon, intends mutually with matched group; Appetite, movable as usual, fur, eye mucosa and respiratory system, none death in 7 days is observed in all no abnormal performance such as central nervous system.The result shows: described drug-breaking medicine does not have acute toxicity to the Cavia porcellus intact skin, also nonirritant.
4.2 Cavia porcellus damaged skin acute toxicity test.
30 of albino guinea-pigs, body weight 280g～320g, grouping, raising, unhairing, medicine, be coated with dose, wrapping method all as previously mentioned, just skin does not scratch corium with oozing of blood and is as the criterion with the wound of parallel stroke 4 vertical long 5cm of scalpel after the unhairing, the same day coating, remove residue with the eliminating cold for resuscitation washing after 24 hours, observed 14 days.
The result: 3 groups of Cavia porcellus wounds do not have red and swollen phenomenon, all healings in 1 week, and viewing duration, animal appetite, activity are all as usual, all no abnormal discovery of fur, eye mucosa, respiratory system, central nervous system.The result shows that described drug-breaking medicine does not have the acute toxicity effect to the Cavia porcellus damaged skin, does not also influence wound healing.
Five, guinea pig skin long term toxicity test
5.1 Cavia porcellus intact skin long term toxicity test.
30 of albino guinea-pigs, body weight 280g～320g, male and female half and half, grouping, are coated with dose, wrapping method all as previously mentioned at raising, unhairing, medicine; It is 2ml every day that 1 group of I of medicine is coated with dose, and it is 1ml every day that 2 groups of II of medicine are coated with dose, and control Group II I is coated with the 3ml distilled water.The coating method: be coated with behind the medicinal liquid wrapping on the 1st 20 hours, with warm water flush away left drug, medicinal liquid of repaste and wrapping after 4 hours, the repaste medicine is 8 days successively, and 9 days was 1 cycle, continuously 3 cycles of coating (27 days).During the coating, observe animal whole body and skin conditions every day, weigh 1 time when the phase finishes weekly.Put to death all animals on the 28th day, each internal organs of gross examination of skeletal muscle skin and whole body have no abnormal.
The result: after 27 days, Cavia porcellus weight increase 90g～100g, specifically as shown in Table 3.During the coating, three treated animal appetite, activity is as usual, hair is smooth, eye mucosa does not have hyperemia, the phenomenon of shedding tears, and coating place skin does not have red and swollen phenomenon, and the heart, lung, liver,spleen,kidney, uterus, testis, gastrointestinal etc. are all no abnormal.
Table three: Cavia porcellus intact skin long term toxicity test---body weight (g) growth pattern table (n=10X ± S).
| Group | Male | Female | ||||||
| Before the medicine | Behind the medicine | Before the medicine | Behind the medicine | |||||
| 1 cycle (9 days) | 2 cycles (18 days) | 3 cycles (27 days) | 1 cycle (9 days) | 2 cycles (18 days) | 3 cycles (27 days) | |||
| I | 365.8± 16.3 | 342.4± 18.9 | 368.8± 28.6 | 398.0± 21.9 | 303.7± 13.6 | 340.7± 13.8 | 366.4± 16.9 | 396.1± 17.1 |
| II | 307.9± | 345.8± | 369.9± | 402.9± | 302.2± | 339.0± | 366.1± | 196.6± |
| 13.3 | 21.9 | 16.8 | 16.1 | 8.85 | 10.9 | 15.0 | 15.9 | |
| III | 308.2± 16.3 | 346.5± 15.9 | 369.1± 19.4 | 398.6± 18.2 | 303.2± 12.4 | 339.1± 14.1 | 367.4± 16.4 | 399.0± 15.3 |
5.2 Cavia porcellus damaged skin long term toxicity test.
30 of albino guinea-pigs, male and female half and half, body weight 280g～320g, grouping, raising, unhairing are all tested item 4.1, and the injured skin method is experiment item 4.2 together, is coated with dose, method and time with testing item 5.1.
The result: Cavia porcellus body weight, activity in 27 days increase 90g～100g, specifically as shown in Table 4, and three treated animal no significant differences.During the coating, none death, three treated animal appetite, activity is as usual, hair is smooth, eyes do not have mucous hyperemia, the phenomenon of shedding tears, little redness when skin wound begins, recovery from illness in the week, each organizes the Cavia porcellus internal organs, gross examination of skeletal muscle is no abnormal, the hemogram measurement result as shown in Table 5, biochemical pointer check result as shown in Table 6, hemogram measurement result and biochemical pointer check result show three treated animal no significant differences.
Table four: Cavia porcellus damaged skin long term toxicity test---body weight (g) growth pattern table (n=10X ± S).
| Group | Male | Female | ||||||
| Before the medicine | Behind the medicine | Before the medicine | Behind the medicine | |||||
| 1 cycle (9 days) | 2 cycles (18 days) | 3 cycles (27 days) | 1 cycle (9 days) | 2 cycles (18 days) | 3 cycles (27 days) | |||
| I | 307.8± 15.4 | 339.8± 19.2 | 368.7± 18.4 | 397.2± 19.4 | 306.4± 13.8 | 334.6± 15.8 | 363.3± 18.9 | 392.2± 19.3 |
| II | 309.4± 14.6 | 338.2± 16.5 | 369.3± 17.6 | 396.5± 18.7 | 305.2± 14.6 | 336.3± 16.7 | 365.7± 19.2 | 394.5± 18.6 |
| III | 308.3± 16.5 | 336.3± 17.5 | 367.5± 15.8 | 401.3± 20.4 | 304.5± 16.3 | 335.2± 17.6 | 367.1± 17.5 | 396.2± 20.1 |
Table five: Cavia porcellus damaged skin long term toxicity test---hemogram measurement result table (n=10X ± S).
| Group | Hemoglobin (g/L) | Erythrocyte * 10 12/L | Platelet * 10 9/L | Leukocyte * 10 9/L | Leukocyte differential count (%) | ||
| Lymph | Neutral | Monokaryon | |||||
| I | 128.2± 12.2 | 4.49± 0.39 | 488.7± 20.8 | 13.2± 1.51 | 69.9± 2.85 | 26.3± 2.25 | 3.56± 1.24 |
| II | 127.7± 11.8 | 4.61± 0.51 | 485.5± 19.2 | 12.5± 1.89 | 69.1± 2.92 | 27.2± 2.86 | 3.70± 0.67 |
| III | 128.6± 13.0 | 4.62± 0.44 | 493.6± 16.1 | 13.2± 2.45 | 69.2± 3.16 | 27.2± 3.12 | 3.54± 0.52 |
Table six: Cavia porcellus damaged skin long term toxicity test---biochemical indicator measurement result table (n=10X ± S).
| Group | Alanine aminotransferase (Ka Menshi unit) | Carbamide ammonia (mmol/L) | Creatinine (μ mol/L) | Total protein (g/L) | Albumin (g/L) | Globulin (g/L) |
| I | 53.8±7.10 | 6.49±1.33 | 63.4±15.6 | 71.3± 2.21 | 33.4± 2.54 | 37.9± 1.29 |
| II | 53.2±8.45 | 6.98±1.36 | 63.8±13.5 | 71.7± 3.30 | 33.0± 2.58 | 38.7± 3.09 |
| III | 57.6±10.7 | 5.54±0.73 | 50.8±10.7 | 71.6± 2.41 | 33.7± 2.69 | 38.5± 2.01 |
Six, guinea pig skin hypersensitive test.
40 of albino guinea-pigs, body weight 250g～300g is divided into 4 groups at random, 1 group of medicine, 2 groups of medicines, negative control group, positive controls, 10 every group, male and female half and half.At skin of back unhairing 4cm * 4cm, the 2nd day begins coating earlier, and the 8th, 15 day respectively repeats once.1 group of medicine and medicine are coated with medicinal liquid 1.0ml respectively for 2 groups at every turn, and negative control group is coated with normal saline at every turn, and (positive controls is coated with 1% dinitrochlorobenzene (DNCB) 0.5ml at every turn for NS, 0.9%NaCl) 1ml.Carried out provocative test in 14 days behind the last coating, on the skin of abdominal part unhairing 3cm * 3cm, 4 treated animals are coated with medicinal liquid 0.5ml respectively, medicinal liquid 0.5ml, NS 0.5ml, 0.1%DNCB0.3ml.
The result: positive controls Cavia porcellus, provocative test are coated with DNCB and promptly occur skin rubefaction, Mild edema phenomenon after a few hours; Two medication groups and NS group there is no the skin rubefaction phenomenon.The result shows that described drug-breaking medicine does not cause the guinea pig skin anaphylaxis.
Experimental result: 1, described drug-breaking medicine is to the Cavia porcellus intact skin, and damaged skin does not all have the acute toxicity effect, and nonirritant does not also influence wound healing; 2, described drug-breaking medicine successive administration is 27 days, and to Cavia porcellus intact skin, damaged skin free of toxic effects, nonirritant does not also influence wound healing; 3, described drug-breaking medicine does not cause the guinea pig skin anaphylaxis.
Should be understood that, for those of ordinary skills, can be improved according to the above description or conversion, and all these improvement and conversion all should belong to the protection domain of claims of the present invention.
Claims (7)
1, a kind of drug-breaking medicine is characterized in that, it is made up of following parts by weight of Chinese traditional medicine material: Agkistrodon 14.25%～15.75%; Periostracum Serpentis 9.5%～10.5%; Scorpio 14.25%～15.75%; Bombyx Batryticatus 9.5%～10.5%; Stigma Croci 6.65%～7.35%; Venenum Bufonis 1.9%～2.1%; Radix Et Rhizoma Rhei 7.6%～8.4%; Herba Scutellariae Barbatae 7.6%～8.4%; Radix Trichosanthis 4.75%～5.25%; Rhizoma Coptidis 9.5%～10.5%; Cortex Moutan 4.75%～5.25%; The Rhizoma Anemarrhenae 4.75%～5.25%.
2, drug-breaking medicine according to claim 1 is characterized in that, wherein the consumption of each composition is an Agkistrodon 15%; Periostracum Serpentis 10%; Scorpio 15%; Bombyx Batryticatus 10%; Stigma Croci 7%; Venenum Bufonis 2%; Radix Et Rhizoma Rhei 8%; Herba Scutellariae Barbatae 8%; Radix Trichosanthis 5%; Rhizoma Coptidis 10%; Cortex Moutan 5%; The Rhizoma Anemarrhenae 5%.
3, drug-breaking medicine according to claim 1 is characterized in that, described drug-breaking medicine external.
4, the preparation method of drug-breaking medicine according to claim 1, it may further comprise the steps: pulverize, dry, sieve, weighing, mixed, high-temperature sterilization, glue.
5, preparation method according to claim 4 is characterized in that, mixed back adds Mel concocts, and the weight ratio of described Mel and drug-breaking medicine is 0.125: 1.
6, preparation method according to claim 4 is characterized in that, it is that 30% wine is concocted that mixed back adds alcohol content, and the weight ratio of described wine and drug-breaking medicine is 0.175: 1.
7, preparation method according to claim 4 is characterized in that, mixed back adds Mel and wine is concocted, and the weight ratio of described Mel and drug-breaking medicine is 0.125: 1; The weight ratio of described wine and drug-breaking medicine is 0.175: 1; The alcohol content of described wine is 30%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100602497A CN100427129C (en) | 2006-04-12 | 2006-04-12 | A drug-breaking medicine and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100602497A CN100427129C (en) | 2006-04-12 | 2006-04-12 | A drug-breaking medicine and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1876094A true CN1876094A (en) | 2006-12-13 |
| CN100427129C CN100427129C (en) | 2008-10-22 |
Family
ID=37508763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100602497A Expired - Fee Related CN100427129C (en) | 2006-04-12 | 2006-04-12 | A drug-breaking medicine and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100427129C (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1297291C (en) * | 2003-11-28 | 2007-01-31 | 罗建会 | Medicine for abstaining from drug addiction and its preparation |
-
2006
- 2006-04-12 CN CNB2006100602497A patent/CN100427129C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN100427129C (en) | 2008-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1208056C (en) | Medicine containing Anemonin as effective component for treating aseptic inflammation | |
| CN1836720A (en) | Chinese medicine composition for treating arthritis or gout and preparing method thereof | |
| CN102579583B (en) | External patch for treating injury of tendons | |
| CN1112836A (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
| CN1836715A (en) | External use medicine for quickly treating herpes zoster | |
| CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
| CN107412338A (en) | A kind of Chinese medicine composition and the plaster containing said composition | |
| CN1965996A (en) | Preparation method of Chinese medicinal capsule for treating apoplexy | |
| CN1876034A (en) | An externally applied analgetic and preparation method thereof | |
| CN101045137A (en) | Capsule for treating epilepsia and its preparing method | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN1883557A (en) | Application of 'Guizhi Gancao Longgu Muli' preparation in preparation of medicine for preventing and treating depression | |
| CN102755480A (en) | External pain-relieving medicament and preparation method thereof | |
| CN1048636C (en) | Special Chinese-medicinal preparation for radically dropping drug | |
| CN100427129C (en) | A drug-breaking medicine and preparation method thereof | |
| CN101011476A (en) | Traditional Chinese medicine composition for drug rehabilitation | |
| CN1274352C (en) | Plaster for treating hyperosteogeny, protrusion of interverterbral disc, arthritis and periarthritis of shoulder joint and its prepn. | |
| CN100344318C (en) | Medicine for treating apoplectic sequel and prepn. thereof | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN1899490A (en) | Liniment for treating acute and chronic soft tissue injury of qi stagnation and blood stasis and its preparing method | |
| CN1186058C (en) | Medicine for treating arthritis pain and its preparation method | |
| CN1406591A (en) | Medicine against aseptic inflammation by ranunculaceae plant and use thereof | |
| CN1201811C (en) | Chinese medicine composition for treating myopia and preparing method thereof | |
| CN1261153C (en) | Drug addiction stopping medicine for opium medicine addict | |
| CN1189376A (en) | Pure Chinese medicine for stopping drugs and its prepn. tech. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081022 Termination date: 20120412 |